ArticleACS applied materials & interfaces2025
Combating Reactive Oxygen Species (ROS) with Antioxidant Supramolecular Polymers.
Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- ROS-Induced DNA Damage Enhances Sensitivity to PARP Inhibition in HSC3 and SCC25 Head and Neck Squamous Cell Carcinoma Cell Lines.Current issues in molecular biology · 2026Article
- Cell-Laden Supramolecular and Covalent Polymer Hydrogels for High-Shear Delivery: A Design of Experiments Approach.Chemistry of materials : a publication of the American Chemical Society · 2026Article
- Eco-friendly synthesis of an antimicrobial polymer (1,4-bis(methacryloyl)piperazine) via maghnite catalysis:Frontiers in chemistry · 2026Article
- Mechanisms and pathways of ROS and autophagy in thyroid cancer.Future science OA · 2025Review
- Genetic Basis of the Antioxidant and Serum Enzyme Activities of the Large Yellow CroakerAntioxidants (Basel, Switzerland) · 2025Article
- Bioactive Supramolecular Polymers for Skin Regeneration Following Burn Injury.Biomacromolecules · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Reactive oxygen species (ROS) are highly damaging biological molecules significantly upregulated following major injuries or diseases such as heart attack, burn injury, and stroke. Despite promising preclinical results, traditional small-molecule antioxidant therapies have had limited success in clinical applications. In this study, we employed a macromolecular approach to combat ROS, demonstrating that tethering the potent biological antioxidant, glutathione, to a peptide amphiphile effectively consumes harmful extracellular radicals while preserving antioxidant and polymeric functionality. By neutralizing these radical species, we can protect vulnerable cells from acute ROS toxicity. This was validated by assessing cellular oxidative damage and survival in cell lines stimulated with tert-butyl hydroperoxide (tBHP) to induce ROS production. The antioxidant nanofibers achieved cell rescue at concentrations an order of magnitude lower than molecular glutathione, a direct result of the extracellular localization and enhancement in the proximal concentration of the glutathione moieties along the supramolecular polymer. These antioxidant supramolecular polymers offer proof of principle for a macromolecular strategy to combat the damaging effects of extracellular ROS associated with disease and injury, showcasing their efficacy at low concentrations and maintaining antioxidant capabilities when in the gelled state, providing for the potential of an antioxidant tissue regenerative scaffold.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.